The antibiotic ADEP reprogrammes CIP, switching it from a regulated to an uncontrolled protease

187Citations
Citations of this article
195Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A novel class of antibiotic acyldepsipeptides (designated ADEPs) exerts its unique antibacterial activity by targeting the peptidase caseinolytic protease P (ClpP). ClpP forms proteolytic complexes with heat shock proteins (Hsp100) that select and process substrate proteins for ClpP-mediated degradation. Here, we analyse the molecular mechanism of ADEP action and demonstrate that ADEPs abrogate ClpP interaction with cooperating Hspi00 adenosine triphosphatases (ATPases). Consequently, ADEP treated bacteria are affected in ClpP-dependent general and regulatory proteolysis. At the same time, ADEPs also activate ClpP by converting it from a tightly regulated peptidase, which can only degrade short peptides, into a proteolytic machinery that recognizes and degrades unfolded polypeptides. In vivo nascent polypeptide chains represent the putative primary target of ADEP-activated ClpP, providing a rationale for the antibacterial activity of the ADEPs. Thus, ADEPs cause a complete functional reprogramming of the Clp-protease complex.

Cite

CITATION STYLE

APA

Kirstein, J., Hoffmann, A., Lilie, H., Schmidt, R., Helga, R. W., Heike, B. O., … Turgay, K. (2009). The antibiotic ADEP reprogrammes CIP, switching it from a regulated to an uncontrolled protease. EMBO Molecular Medicine, 1(1), 37–49. https://doi.org/10.1002/emmm.200900002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free